Delivery Order HHSN261201500039I-HHSN26100004
Award Date
9/8/16
Potential Completion Date
9/7/22
Potential Value
$1.2M
Federal Agency
National Cancer Institute
Ultimate Awardee
Cornell University
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10065, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Weill Medical College of Cornell University was awarded a delivery order against the PREVENT Cancer Program (PREVENT) multiple award IDIQ by the National Cancer Institute, an agency of the Department of Health and Human Services. The delivery order has a potential value of $891,983.59 to support the development of a Frameshift Peptide Vaccine for the Prevention of Lynch Syndrome-Associated Gastrointestinal Cancer. No set-aside designation was used for this award. The period of performance is...
This is a delivery order under the Preclinical Agent Development Assays 2012-2016 Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI) to the Weill Medical College of Cornell University. The order is for $614,987.25 and covers preclinical in vitro and in vivo agent development assays and blood-based biomarkers of obesity-induced breast inflammation. This work supports the NCI's PREVENT Cancer Preclinical Drug Development Program, which aims to transition cancer...
This firm fixed price delivery order contract was awarded to The Institute for Cancer Research, a non-profit subsidiary of Temple University, by the National Cancer Institute (NCI). The contract is a task order under the larger "PREVENT Preclinical Drug Development Program (PREVENT)" indefinite delivery contract, which aims to provide preclinical efficacy and biomarker analysis services to support the evaluation of candidate chemopreventive and immunopreventive regimens. This...
This federal contract award, with an ID of N0014098G2436|N0622A25FA076, was issued by the Department of the Navy (an agency of the Department of Defense) to the Weill Medical College of Cornell University. The $38,000.00 firm fixed-price delivery order is for tuition and fees, with a completion date of May 30, 2025. Weill Medical College of Cornell University is a prestigious academic medical institution that frequently engages with federal agencies, including the National Institutes of Health...
This federal contract award was issued by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to The Institute for Cancer Research, a non-profit organization and subsidiary of Temple University. The $1,570,991.00 task order is part of the PREVENT Preclinical Drug Development Program, which focuses on preclinical efficacy and intermediate endpoint biomarker testing for cancer prevention drug candidates. The task order is for a project titled...
The provided information describes a federal contract award to Weill Medical College of Cornell University, a prestigious private research university. The contract, with an award value of $9,437,194.06, is for biomedical research services and is managed by the National Heart, Lung, and Blood Institute, a civilian agency within the National Institutes of Health. The contract is a definitive contract with a cost-no-fee pricing type, indicating it is for the delivery of specific research...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Weill Medical College of Cornell University, a private non-profit research university. The $89,805.60 firm fixed-price delivery order contract is for tuition and fees, with a period of performance ending on December 31, 2016. The college is performing the work in New York, NY. Weill Medical College is an experienced federal contractor that has received numerous grant awards from agencies like the...
This is a delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to The Institute for Cancer Research, a non-profit research organization and subsidiary of Temple University. The $988,252 firm fixed price contract is for research and development services in the area of biomedical basic research, specifically preclinical efficacy and biomarker analysis to support the NCI's PREVENT Cancer Preclinical Drug Development Program....
This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a prestigious private research university. The contract, valued at $994,896.00, is for the development of rabbit animal models of ventilator-associated bacterial pneumonia produced by Carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. This work is being conducted under Broad Agency Announcement (BAA) 19-00123, PMWP#132. The contract has a firm...
This federal contract award is for tuition and fees to be provided by Weill Medical College of Cornell University, a prestigious private research university focused on biomedical research and medical education. The contract, valued at $91,140.00, was awarded on January 1, 2017 by the Bureau of Medicine and Surgery, a subcomponent of the Department of Defense. The contract is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is June 30, 2017. While no...